Acinetobacter baumannii resistant to colistin with impaired virulence: A case report from France

Journal of Infectious Diseases

Volumn 204, Issue 7, 2011, Pages 1146-1147

  Rolain, Jean Marc ^a   Roch, Antoine ^a,b   Castanier, Matthias ^a,b   Papazian, Laurent ^a,b   Raoult, Didier ^a  

^a CNRS   (France)

^b HÔPITAL NORD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; CLAVULANIC ACID; COLISTIN; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; SPIRAMYCIN;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ACUTE RESPIRATORY FAILURE; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; BACTERIURIA; BLOOD CULTURE; CASE REPORT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; ENDOTRACHEAL INTUBATION; EXTRACORPOREAL OXYGENATION; FEVER; FLU LIKE SYNDROME; FRANCE; HUMAN; HYPOXEMIA; INTENSIVE CARE; LETTER; LOBAR PNEUMONIA; LUNG LAVAGE; MALE; PRIORITY JOURNAL; SEPTIC SHOCK; THORAX RADIOGRAPHY; URINE CULTURE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANIMALS; ANTI-BACTERIAL AGENTS; COLISTIN; DRUG RESISTANCE, BACTERIAL; FEMALE;

EID: 80052400016     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir475     Document Type: Letter

References (10)

1. Lopez-Rojas R., Dominguez-Herrera J., McConnell M.J., et al. Impaired virulence and in vivo fitness of colistin-resistant Acinetobacter baumannii. J Infect Dis 2011; 203:545-548
2. Peleg A.Y., Seifert H., Paterson D.L. Acinetobacter baumannii: Emergence of a successful pathogen. Clin Microbiol Rev 2008; 21:538-582
3. Moffatt J.H., Harper M., Harrison P., et al. Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production. Antimicrob Agents Chemother 2010; 54:4971-4977
4. Valencia R., Arroyo L.A., Conde M., et al. Nosocomial outbreak of infection with pandrug- resistant Acinetobacter baumannii in a tertiary care university hospital. Infect Control Hosp Epidemiol 2009; 30:257-263
5. Alhanout K., Brunel J.M., Raoult D., Rolain J.M. In vitro antibacterial activity of aminosterols against multidrug-resistant bacteria from patients with cystic fibrosis. J Antimicrob Chemother 2009; 64:810-814
6. Alhanout K., Malesinki S., Vidal N., Peyrot V., Rolain J.M., Brunel J.M. New insights into the antibacterial mechanism of action of squalamine. J Antimicrob Chemother 2010; 65:1688-1693
7. Adams M.D., Nickel G.C., Bajaksouzian S., et al. Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system. Antimicrob Agents Chemother 2009; 53:3628-3634
8. Moffatt J.H., Harper M., Adler B., Nation R.L., Li J., Boyce J.D. The insertion sequence ISAba11 is involved in colistin resistance and loss of lipopolysaccharide in Acinetobacter baumannii. Antimicrob Agents Chemother 2011; 55:3022-3024
9. Andersson D.I., Hughes D. Antibiotic resistance and its cost: Is it possible to reverse resistance? Nat Rev Microbiol 2010; 8:260-271
10. Rolain J.M., Parola P., Cornaglia G. New Delhi metallo-beta-lactamase (NDM-1): Towards a new pandemia? Clin Microbiol Infect 2010; 16:1699-1701